STOCK TITAN

LOGIQ INC - LGIQ STOCK NEWS

Welcome to our dedicated page for LOGIQ news (Ticker: LGIQ), a resource for investors and traders seeking the latest updates and insights on LOGIQ stock.

Logiq, Inc. develops e-commerce, m-commerce, marketing technology, and fintech solutions for mobile users. The company provides AppLogiq, a platform that enables SMBs to create native mobile apps in multiple languages across various markets. Their AI-driven data engine, DataLogiq, captures consumer intent to boost leads, engagement, and conversion. Additionally, Logiq offers LogiqX for consumer insights, PayLogiq for mobile payments, and GoLogiq for food delivery. With a focus on digital customer acquisition, Logiq simplifies digital advertising and delivers data-driven marketing solutions.

Rhea-AI Summary

Logiq, Inc. (OTC PINK:LGIQ) has announced a definitive agreement to acquire EVIMATE, a medical device innovation company, for $5 million. This acquisition marks Logiq's entry into the medical device sector. EVIMATE specializes in advanced vital sign monitoring products that utilize AI technology for comprehensive health metric tracking and predictive analytics.

EVIMATE's solution includes next-generation devices and a user-friendly app that continuously monitors key health indicators such as temperature, heart rate, ECG, blood pressure, oxygen levels, and glucose levels. The system is designed for Remote Patient Monitoring (RPM), providing real-time insights and alerts to healthcare providers, caregivers, and family members.

Additionally, EVIMATE has developed an automotive healthcare system for monitoring driver vitals, featuring sensors in the driver's seat and steering wheel to collect vital signs like heart functions, respiratory rate, stress level, and blood oxygen level. All devices mentioned will require FDA regulatory approvals and additional patent filings for IP protection.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
-
Rhea-AI Summary

Logiq, Inc. (OTC:LGIQ) has announced a definitive agreement to acquire MedLab Essentials, , a leader in cell and gene therapy innovation, in a deal valued at $100 million. The acquisition will be executed through a share exchange, with MedLab becoming a wholly owned subsidiary of Logiq. Key highlights include:

1. Logiq shareholders will retain 15% post-transaction
2. The combined entity aims to uplist to Nasdaq, CBOE, or NYSE
3. A substantial capital raise is planned by the end of 2024
4. This marks Logiq's first step in a series of biotech acquisitions targeting a cumulative value over $750 million

This strategic move signifies Logiq's diversification into the biotech sector, particularly focusing on cell and gene therapy assets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.05%
Tags
-
Rhea-AI Summary

Logiq has signed a binding letter of intent to acquire MedLab Essentials for $100 million in a share exchange deal. MedLab will become a wholly-owned subsidiary, with its executives joining Logiq's senior management.

This acquisition diversifies Logiq into the biotech sector and aims for a Nasdaq, CBOE, or NYSE uplisting by Q3 2024. Post-transaction, Logiq shareholders will retain 15% of the company. This is part of a broader strategy to expand into biotech and cell and gene therapy, targeting a cumulative value exceeding $750 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.17%
Tags
Rhea-AI Summary
DLQ, Inc. provides an update on its pending merger with ABRI SPAC I, Inc. The registration statement for the merger has been declared effective by the SEC. Logiq has scheduled a special meeting of its stockholders on October 23, 2023, to seek approval for the merger. The combined company is expected to be renamed 'Collective Audience, Inc.' and listed on Nasdaq under the ticker symbols 'CAUD' and 'CAUDW'. The merger is expected to close in Q4 2023, subject to approvals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.7%
Tags
-
Rhea-AI Summary
Logiq reports Q2 2023 revenues of $4.86 million, increasing 37% sequentially and 47% YoY. Pending SPAC merger with ABRI SPAC I expected to provide a listing on a senior stock exchange. DataLogiq subsidiary SPAC merger in progress. Struggling IPO market increases value of public reporting companies like Logiq. Late-stage discussions with potential M&A targets. Park Place Payments business solid, growth dependent on funding. New product lines planned for launch. Acquisition targets expected to drive revenue growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.11%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.32%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.77%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.77%
Tags
AI
Rhea-AI Summary

Logiq, Inc. (OTCQX: LGIQ) has announced the acquisition of Park Place Payments, a fintech company specializing in merchant payment solutions. This all-stock transaction is valued at over $6 million, contingent upon meeting specific milestones. Park Place operates within the gig economy, boasting more than 1,500 account executives and generating over $5 million in revenue with an annualized transaction volume exceeding $180 million. The acquisition is expected to enhance Logiq's digital marketing capabilities and expand its fintech offerings to a broader array of small businesses. Park Place aims to grow its sales team to 40,000 executives in the coming years, potentially yielding $15 million in additional revenue for Logiq within a year. This strategic move aligns with Logiq's ongoing M&A strategy to enhance its direct-to-consumer and B2B business model.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.37%
Tags

FAQ

What is the current stock price of LOGIQ (LGIQ)?

The current stock price of LOGIQ (LGIQ) is $0.007975 as of December 23, 2024.

What is the market cap of LOGIQ (LGIQ)?

The market cap of LOGIQ (LGIQ) is approximately 4.2M.

What solutions does Logiq, Inc. provide?

Logiq offers e-commerce, marketing technology, and fintech enablement solutions for mobile users.

What is AppLogiq?

AppLogiq is a platform-as-a-service (PaaS) platform that allows small and medium-sized businesses to create and deploy native mobile applications.

What is DataLogiq?

DataLogiq is Logiq's martech AI-driven data engine that captures and directs consumer intent to enhance leads, engagement, and monetary conversion.

What are the key products offered by Logiq?

LogiqX for consumer insights, PayLogiq for mobile e-wallet and payments, and GoLogiq for food delivery.

Where is Logiq, Inc. headquartered?

Logiq, Inc. is headquartered in New York, New York.

What does Logiq focus on in terms of digital advertising?

Logiq focuses on streamlining digital advertising, providing data-driven marketing solutions for customer engagement.

What is the recent strategic acquisition by Logiq?

Logiq recently signed a binding letter of intent to acquire MedLab Essentials, LLC, a cell and gene therapy innovator, marking a milestone diversification into the biotech sector.

What is the estimated value of the acquisition?

The acquisition of MedLab Essentials, LLC is valued at approximately $100 million.

What are the anticipated outcomes of the MedLab acquisition?

The acquisition is expected to propel Logiq into the biotech domain, fostering innovation in cell and gene therapies for longevity, anti-aging, and life extension.

What was Logiq, Inc.'s reported revenue for Q2 2023?

Logiq reported revenues of approximately $4.86 million for the second quarter ended June 30, 2023, showing a significant increase.

LOGIQ INC

OTC:LGIQ

LGIQ Rankings

LGIQ Stock Data

4.19M
268.62M
3.88%
Software - Application
Technology
Link
United States of America
New York